Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer

NCT06972576 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

BIOLOGICAL: EphA2-targeted CAR-T Cells
BIOLOGICAL: EphA2-targeted CAR-DCs

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University